Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MMP13 | P45452 | 1/20 | 0.58 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5335606 | 1.00 | PKM (0.70) | PKMHPGDKMT2AMEN1RAB9A | |
| SCHEMBL5338096 | 0.95 | PKM (0.77) | PKMHPGDKMT2AMEN1TDP1 | |
| SCHEMBL5334385 | 0.91 | PKM (0.69) | PKMHPGDKMT2AMEN1TDP1 | |
| SCHEMBL5334387 | 0.91 | PKM (0.69) | PKMHPGDKMT2AMEN1TDP1 | |
| SCHEMBL1042327 | 0.88 | RAB9A (0.78) | KMT2AMEN1RAB9ATDP1ALDH1A1 | |
| SCHEMBL5334043 | 0.87 | CYP1A2 (0.65) | KMT2AMEN1RAB9ATDP1ALDH1A1 | |
| SCHEMBL5338191 | 0.86 | MEN1 (0.80) | HPGDKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL5335908 | 0.85 | PKM (0.64) | PKMHPGDKMT2AMEN1RAB9A | |
| SCHEMBL5337784 | 0.85 | PKM (0.64) | PKMHPGDKMT2AMEN1RAB9A | |
| SCHEMBL5331587 | 0.85 | NPC1 (0.67) | PKMHPGDRAB9ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3802847-A1 | INCREASING EFFICIENCY OF PHOTOCHEMICAL REACTIONS ON SUBSTRATES | Centrillion Technologies, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| US-20060025396-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | BARVIAN NICOLE C | 2006-02-02 | — | — | US | claimed |
| EP-1362028-A2 | ISOPHTHALIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | Warner-Lambert Company LLC (US) | 2003-11-19 | — | — | EP | claimed |
| US-20020156061-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | BARVIAN NICOLE CHANTEL (US) | 2002-10-24 | — | — | US | claimed |
| WO-2002064547-A2 | ISOPHTHALIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | claimed |
| WO-1996032459-A1 | FIRE RETARDANT AND METHOD FOR PREPARATION | AMERICAN UNI-TECH, INC. (US) | 1996-10-17 | — | — | WO | claimed |
| US-5405555-A | Mixture of ammonium sulfate, boric acid, borax, hydrogen perox peroxide and an alkyl phthalate ester | AMERICAN UNI-TECH, INC. (US) | 1995-04-11 | — | — | US | claimed |
| EP-0500820-A4 | IMPROVED SPRAY FORMULATION FOR THE TESTING OF SMOKE DETECTORS | — | 1993-06-02 | — | — | EP | claimed |
| EP-0500820-A1 | IMPROVED SPRAY FORMULATION FOR THE TESTING OF SMOKE DETECTORS | COOPER, Leon (US) | 1992-09-02 | — | — | EP | claimed |
| US-5139699-A | Mixtures of hydrocarbon propellants, dialkyl phthalate esters, for manual spraying from aerosol containers | HOME SAFEGUARD INDUSTRIES, L.L.C. | 1992-08-18 | — | — | US | claimed |
| WO-1992000240-A1 | IMPROVED SPRAY FORMULATION FOR THE TESTING OF SMOKE DETECTORS | COOPER LEON (US) | 1992-01-09 | — | — | WO | claimed |
| US-5041365-A | Containing magenta coupler and stain inhibitory additive | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-20 | — | — | US | claimed |
| US-4983507-A | CONTAINING MAGENTA COLOR IMAGE-FORMING OLEOPHILIC COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1991-01-08 | — | — | US | claimed |
| EP-0230048-B1 | SILVER HALIDE COLOR PHOTOGRAPHIC MATERIALS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-07-04 | — | — | EP | claimed |
| US-4704350-A | PREVENTION OF STAINS DURING DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1987-11-03 | — | — | US | claimed |
| EP-0230048-A2 | Silver halide color photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1987-07-29 | — | — | EP | claimed |
| WO-2015092410-A1 | FIRE RETARDANT COMPOSITION | AL-HAJAM ESTABLISHMENT (VOLUME TRADING) (SA) | 2015-06-25 | — | — | WO | disclosed |
| CN-104341256-A | Low-cost and environment-friendly synthesis method of biphenyl derivatives | HARBIN INST TECH WEIHAI | 2015-02-11 | — | — | CN | disclosed |
| EP-0236131-A2 | Silver halide color photographic material | KONICA CORPORATION (JP) | 1987-09-09 | — | — | EP | disclosed |
| EP-0228064-A2 | Photographic elements with sterically hindered photographic coupler solvents | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060025396-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | MMP13, MMP11, MMP3 | PKM 4774/4885HPGD 353/4885KMT2A 3382/4885 |
| US-20020156061-A1 | Isophthalic acid derivatives as matrix metalloproteinase inhibitors | MMP13, MMP1, MMP11 | PKM 4791/4885HPGD 189/4885KMT2A 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.